Perspective
International Journal of Impotence Research (2006) 18, 499–500. doi:10.1038/sj.ijir.3901450; published online 19 January 2006
The future of sexual medicine for the urologist
L S Ross1
1Department of Urology, University of Illinois at Chicago, Chicago, IL, USA
Correspondence: Dr LS Ross, Department Of Urology (M/C 955), The University of Illinois at Chicago, 820 S. Wood Street, Suite 515 CSN, Chicago, IL 60612, USA. E-mail: cseydel@uic.edu
Received 29 November 2005; Accepted 29 November 2005; Published online 19 January 2006.
Abstract
Editor's note: Winston Churchill said, 'I never worry about action, but only inaction'. Experience has taught the medical profession that action, change and adaptation are the rule as novel technologies and therapies are introduced into the mainstream of medical care. Sexual medicine is no exception. Originally thought to be psychogenic in origin, it is now well accepted that erectile dysfunction (ED) is predominately organic in origin in most middle-aged men. Treatment of organic ED has evolved with the introduction of novel, oral therapies, such as phosphodiesterase inhibitors. Adaptation has also led to incorporation of ED into the treatment realm of the primary-care physician. As sexual medicine becomes increasingly non-surgical, the challenge to the surgical specialists will reside in their ability to change and adapt to this ever-burgeoning medical discipline. Lawrence Ross, President-Elect of the American Urological Association, discusses action and change below. If urologists are to remain involved in sexual medicine, then his action plan must be brought to fruition.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
International Journal of Impotence Research Original Article
International Journal of Impotence Research Original Article
